EdwinJamesWhitneyMD

PubMed

• 5 citations
  The Effect of Gemfibrozil, Niacin and Cholestyramine Combination Therapy on Metabolic Syndrome in the Armed Forces Regression Study
  Richard A. Krasuski, Ganesh P. Devendra, George Cater, Edwin J. Whitney> ;The American Journal of the Medical Sciences. 2011 May 1
• 4 citations
  Impact of increases in high-density lipoprotein cholesterol on cardiovascular outcomes during the armed forces regression study.
  Ganesh P. Devendra, Edwin J. Whitney, Richard A. Krasuski> ;Journal of Cardiovascular Pharmacology and Therapeutics. 2010 Aug 5
• 7 citations
  Impact of Fibrinogen Levels on Angiographic Progression and 12-Year Survival in the Armed Forces Regression Study
  Ganesh P. Devendra, Stephen A. Hart, Edwin J. Whitney, Richard A. Krasuski> ;Angiology. 2010 Mar 19
• 36 citations
  Effects of combination lipid therapy on coronary stenosis progression and clinical cardiovascular events in coronary disease patients with metabolic syndrome: a combin...
  Xue Qiao Zhao, Richard A. Krasuski, Jefferson Baer, Edwin J. Whitney, Blazej Neradilek, Alan Chait, Santica M. Marcovina, John J. Albers, B. Greg Brown> ;The American Journal of Cardiology. 2009 Dec 1
• 173 citations
  A Randomized Trial of a Strategy for Increasing High-Density Lipoprotein Cholesterol Levels: Effects on Progression of Coronary Heart Disease and Clinical Events
  Edwin J. Whitney, Richard A. Krasuski, Bradley E. Personius, Joel E. Michalek, Ara M. Maranian, Mark W. Kolasa, Erik Monick, B. Gregory Brown, Antonio M. Gotto> ;Annals of Internal Medicine. 2005 Jan 18
• 74 citations
  Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): efficacy and tolerability of long-term treatment with lovastatin in women.
  Michael Clearfield, John R. Downs, Stephen E. Weis, Edwin J. Whitney, William Kruyer, Deborah R. Shapiro, Evan A. Stein, Alexandra Langendorfer, Polly A. Beere, Antoni...> ;Journal of Women's Health & Gender-Based Medicine. 2001 Dec 1
• 101 citations
  Air force/texas coronary atherosclerosis prevention study (afcaps/texcaps): Additional perspectives on tolerability of long-term treatment with lovastatin
  John R. Downs, Michael Clearfield, H.Alfred Tyroler, Edwin J. Whitney, William Kruyer, Alexandra Langendorfer, Vladimir Zagrebelsky, Stephen E. Weis, Deborah R. Shapir...> ;The American Journal of Cardiology. 2001 May 1
• 25 citations
  Effect of lovastatin on cardiovascular resource utilization and costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
  Antonio M. Gotto, Stephen J. Boccuzzi, John R. Cook, Charles M. Alexander, James B. Roehm, Gregg S. Meyer, Michael Clearfield, Stephen E. Weis, Edwin J. Whitney> ;The American Journal of Cardiology. 2000 Dec 1
• 16 citations
  Application of the National Cholesterol Education Program and joint European treatment criteria and clinical benefit in the Air Force/Texas Coronary Atherosclerosis Pr...
  Antonio M. Gotto, Edwin J. Whitney, Evan A. Stein, Deborah R. Shapiro, Michael Clearfield, Stephen E. Weis, J. Y. Jou, Alexandra Langendorfer, Polly A. Beere, Douglas ...> ;European Heart Journal. 2000 Oct 1
• Rofecoxib and the risk of adverse upper gastrointestinal effects.
  Whitney E> ;JAMA. 2000-04-19
• 11 citations
  Air force/Texas Coronary Atherosclerosis Prevention study (AFCAPS/TexCAPS): Baseline Characteristics and comparison with USA population
  Michael Clearfield, Edwin J. Whitney, Stephen E. Weis, John R. Downs, Deborah R. Shapiro, Evan A. Stein, Douglas J. Watson, Alexandra Langendorfer, Polly A. Beere, Jer...> ;Journal of Cardiovascular Risk. 2000 Apr 1
• 436 citations
  Relation Between Baseline and On-Treatment Lipid Parameters and First Acute Major Coronary Events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFC...
  Antonio M. Gotto, Edwin J. Whitney, Evan A. Stein, Deborah R. Shapiro, Michael Clearfield, Stephen E. Weis, Jesse Y. Jou, Alexandra Langendorfer, Polly A. Beere, Dougl...> ;Circulation. 2000 Feb 8
• 2 citations
  The Air Force/Texas Coronary Atherosclerosis Prevention Study: implications for preventive cardiology in the general adult US population.
  Edwin J. Whitney> ;Current Atherosclerosis Reports. 1999 Jul 1
• 10 citations
  Cholesterol-lowering therapy.
  Schuff-Werner P, Schettler, Schulz E> ;Circulation. 1997 Nov 18
• 42 citations
  Effect of gemfibrozil +/- niacin +/- cholestyramine on endothelial function in patients with serum low-density lipoprotein cholesterol levels <160 mg/dl and high-densi...
  Thomas C. Andrews, Edwin J. Whitney, Garfield G. Green, Robert Kalenian, Bradley E. Personius> ;The American Journal of Cardiology. 1997 Oct 1
• 132 citations
  Design & Rationale of the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
  John R. Downs, Polly A. Beere, Edwin J. Whitney, Michael Clearfield, Stephen E. Weis, Jeffrey Rochen, Evan A. Stein, Deborah R. Shapiro, Alexandra Langendorfer, Antoni...> ;The American Journal of Cardiology. 1997 Aug 1
• 9 citations
  Effect of a Combination of Gemfibrozil and Niacin on Lipid Levels
  Gregory A. Spencer, Stewart R. Wirebaugh, Edwin J. Whitney> ;Journal of Clinical Pharmacology. 1996 Aug 1
• 9 citations
  Changing presentation of coronary heart disease in an inpatient population within the U.S. military health care system.
  A. Landon Wellford, Thomas L. Ashcom, Edwin J. Whitney, Bernard J. Rubal, Lou Anne Wellford, Joe M. Moody> ;Military Medicine. 1993 Sep 1
• 15 citations
  A Retrospective Review of the Use of Lipid-Lowering Agents in Combination, Specifically, Gemfibrozil and Lovastatin
  Stewart R. Wirebaugh, Michael L. Shapiro, Thomas H. McLntyre, Edwin J. Whitney> ;Pharmacotherapy. 1992 Nov 12
• 9 citations
  The case for unstable angina pectoris as a primary end point in primary prevention studies.
  Edwin J. Whitney, Charles L. Shear, Geraldine Mantell, Eva Lydick, Robert Wolf> ;The American Journal of Cardiology. 1992 Sep 15
• 5 citations
  Reversibility of fixed atherosclerotic lesions with aggressive risk factor modification.
  Edwin J. Whitney, Thomas L. Ashcom, Richard K. Hantman, James Heironimus> ;Military Medicine. 1991 Aug 1
• 1 citations
  Cardiovascular risk modification: a multidisciplinary approach in a USAF clinic setting.
  Whitney Ej, Boswell Rn> ;Military Medicine. 1986 Sep 1
• New methods for effective cardiac care.
  Whitney, E. J.> ;J Cardiovasc Manag. 1996 Jul 01
• Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Ather...
  Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, A. M.> ;JAMA. 1998 May 27
• Join now to see all